乳腺弥漫大B细胞淋巴瘤9例临床病理特征分析(3)
[6]Jung SP，Han KM，Kim SJ，et al.Primary follicular lymphoma in a male breast：a case report[J].Cancer Res Treat，2014，46(1)：104-107.
[7]Hosein PJ，Maragulia JC，Salzberg MP，et al.A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era[J].Br J Haematol，2014，165(3)：358-363.
[8]Surov A，Holzhausen HJ，Wienke A，et al.Primary and secondary breast lymphoma：prevalence，clinical signs and radiological features[J].Br Radiol，2012，85(1014)：e195-e205.
[9]Cheah CY，Campbell BA，Seymour JF.Primary breast lymphoma[J].Cancer Treat Rev，2014，40(8)：900-908.
[10]Rooney N，Snead D，Goodman S，et al.Primary breast lymphoma with akin involvement arising in lymphocytic lobulitis[J].Histopathology，1994，24(1)：81-84.
[11]Teras IR，Patel AV，Hildebrand JS，et al.Posunenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the An]efiean Cancer Society Cancer Prevention Study-1I Cohoa[J].Leuk Lynrphoma，2013，54(4)：720-725.
[12]Ganjoo K，Advani R，Mariappan MR，et al.Non-Hodgkin lymphoma of the breast[J].Cancer，2007，110(1)：25-30.
[13]郭庆，沈勤，王少华，等.原发眭乳腺恶性淋巴瘤36例临床病理分析[J].临床与实验病理学杂志，2012，28(11)：1206-1210.
[14]Ryan G，Martinelli G，Kuper-Hommel M，et al.Primary diffuse large B-cell lymphoma of the breast：prognostic factors and outcomes of a study by the lnternational Extranodal Lymphoma Study Group[J].Ann Oncol，2008，19(2)：233-241.
[15]Radkani P，Joshi D，Paramo JC，et al.Primary breast lymphoma：30 years of experience with diagnosis and treatment at a single medical center[J].JAMA Surg，2014，32(2)：114-120.
(收稿日期：2017-09-18 本文編辑：闫 佩), http://www.100md.com(涂剑宏 瞿伟)
[7]Hosein PJ，Maragulia JC，Salzberg MP，et al.A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era[J].Br J Haematol，2014，165(3)：358-363.
[8]Surov A，Holzhausen HJ，Wienke A，et al.Primary and secondary breast lymphoma：prevalence，clinical signs and radiological features[J].Br Radiol，2012，85(1014)：e195-e205.
[9]Cheah CY，Campbell BA，Seymour JF.Primary breast lymphoma[J].Cancer Treat Rev，2014，40(8)：900-908.
[10]Rooney N，Snead D，Goodman S，et al.Primary breast lymphoma with akin involvement arising in lymphocytic lobulitis[J].Histopathology，1994，24(1)：81-84.
[11]Teras IR，Patel AV，Hildebrand JS，et al.Posunenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the An]efiean Cancer Society Cancer Prevention Study-1I Cohoa[J].Leuk Lynrphoma，2013，54(4)：720-725.
[12]Ganjoo K，Advani R，Mariappan MR，et al.Non-Hodgkin lymphoma of the breast[J].Cancer，2007，110(1)：25-30.
[13]郭庆，沈勤，王少华，等.原发眭乳腺恶性淋巴瘤36例临床病理分析[J].临床与实验病理学杂志，2012，28(11)：1206-1210.
[14]Ryan G，Martinelli G，Kuper-Hommel M，et al.Primary diffuse large B-cell lymphoma of the breast：prognostic factors and outcomes of a study by the lnternational Extranodal Lymphoma Study Group[J].Ann Oncol，2008，19(2)：233-241.
[15]Radkani P，Joshi D，Paramo JC，et al.Primary breast lymphoma：30 years of experience with diagnosis and treatment at a single medical center[J].JAMA Surg，2014，32(2)：114-120.
(收稿日期：2017-09-18 本文編辑：闫 佩), http://www.100md.com(涂剑宏 瞿伟)